EndoLogic Acquires Renzapride from Alizyme, plc
Jan 03, 2017 13:02 pm UTC| Business
CLIFTON, N.J., Jan. 03, 2017 -- EndoLogic, a company focused on the development and commercialization of products that treat gastrointestinal diseases, has acquired the worldwide rights to the clinical-stage asset,...
AMAG Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 03, 2017 13:02 pm UTC| Business
WALTHAM, Mass., Jan. 03, 2017 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, chief executive officer, will present at the 35thAnnual J.P. Morgan Healthcare Conference on Tuesday,...
AMAG Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 03, 2017 13:02 pm UTC| Business
WALTHAM, Mass., Jan. 03, 2017 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, chief executive officer, will present at the 35thAnnual J.P. Morgan Healthcare Conference on Tuesday,...
AMAG Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 03, 2017 13:01 pm UTC| Business
WALTHAM, Mass., Jan. 03, 2017 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, chief executive officer, will present at the 35thAnnual J.P. Morgan Healthcare Conference on Tuesday,...
AveXis to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 03, 2017 13:01 pm UTC| Business
CHICAGO, Jan. 03, 2017 -- AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced Sean...
AveXis to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 03, 2017 13:01 pm UTC| Business
CHICAGO, Jan. 03, 2017 -- AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced Sean...
Jan 03, 2017 13:01 pm UTC| Business
SAN DIEGO, Jan. 03, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...